In the three decades since the performance of the first human heart transplant in December 1967, the procedure has changed from an experimental operation to an established treatment for advanced heart disease. Approximately 2,300 heart transplants are performed each year in the United States.
In 1981, combined heart and lung transplants began to be used to treat patients with conditions that severely damage both these organs. As of 1995, about 500 people in the United States and 2,000 worldwide have received heart-lung transplants.
There have been two main barriers to increasing the number of successful operations. In 1983, the first barrier to successful transplantations--rejection of the donor organ by the patient--was overcome. The drug cyclosporine was introduced to suppress rejection of a donor heart or heart-lung by the patient's body. Cyclosporine and other medications to control rejection have significantly improved the survival of transplant patients. About 80 percent of heart transplant patients survive 1 year or more. About 60 percent of heart-lung transplants live at least 1 year after surgery. Research is under way to develop even better ways to control transplant rejection and improve survival.
Organ availability is the second barrier to increasing the number of successful transplantations. Hospitals and organizations nationwide are trying to increase public awareness of this problem and improve organ distribution.
Cardiology Associates of Fort Lauderdale, P.A.
4725 N. Federal Hwy, Suite #401
The Jim Moran Heart and Vascular Center
Fort Lauderdale, FL 33308
Phone: (954) 772-2136
Fax: (954) 772-7156